Pre-callModerate confidence$202.68Weekend · last close
Most important: Scorpio fabric switch customer ramp proofIn the print: revenue, gross margin, Q2 2026 guide midpointOn the call: Scorpio hyperscaler timing, Taurus AEC revenueRisk: beat without Scorpio diversification leaves concentration intact
House view
Street treats ALAB as a hyperscaler capex momentum name. The thesis fork is whether Scorpio fabric switches are shipping to new hyperscalers on schedule. A revenue beat without Scorpio customer proof leaves single-product concentration risk unchanged.
What is priced in
Consensus models $292M revenue and $0.54 EPS, both inside the guided $286M to $297M range. A modest beat is expected given ALAB's pattern of guiding conservatively (Q4 2025 beat by 12.4%). Underweighted: Scorpio P Series shipment timing into the two additional hyperscalers disclosed last quarter, and whether 800G Taurus AEC revenue has started. The stock prices continued Aries retimer dominance but does not yet price Scorpio becoming the largest product line.
What decides the quarterRanked by thesis impact
Priority 1 · thesis-defining
Scorpio fabric switch customer ramp proof
ALAB guided initial Scorpio X shipments in 2026 and Scorpio P shipments to at least two new hyperscalers. Confirmation would validate the transition from a retimer company to a multi-product platform. This is the thesis fork.
✓Management confirms Scorpio P shipments to two or more new hyperscalers have commenced, with Scorpio revenue share cited at or above 10% of total.
✗Scorpio shipments delayed to H2 2026 or later, paired with customer count unchanged at one, or hedging language on the two new hyperscaler wins.
Priority 2
Gross margin durability through product mix shift
GM has held in the 74.9% to 76.2% band for four quarters. A Scorpio ramp could compress margins if initial pricing is lower than mature Aries retimer ASPs. Sustained GM above 75% during a mix shift would signal pricing power across the portfolio.
✓Non-GAAP GM at or above 75% with Scorpio revenue growing as a share, plus Q2 2026 GM guide holding the band.
✗GM below 74% paired with commentary attributing the decline to new product ramp pricing or different customer mix.
Priority 3
Q2 2026 revenue guide acceleration
Sequential growth decelerated from 17% in Q4 to a guided 6% to 10% in Q1. The Q2 guide will show whether this is seasonal or a structural slowdown. A guide implying sequential acceleration above 10% could support continued 80%+ YoY growth.
Working the eventRelease drop vs. Q&A
In the release · first 60 seconds
Revenue
$292M consensus; guided range $286M to $297M
Check total revenue vs. the $297M top of guide. Look for any product-level breakdown mentioning Scorpio or Aries share.
Non-GAAP Gross Margin
75.7% (Q4 2025 non-GAAP)
Check whether GM holds above 75%. Any sequential compression below 74.9% warrants checking the product mix commentary.
Non-GAAP EPS
$0.54 consensus; $0.58 prior quarter
Check EPS vs. $0.54 consensus. Note the magnitude of any beat relative to the Q4 pattern ($0.58 vs. $0.516 est).
Q2 2026 Revenue Guide
No prior guide; Q1 guided $286M to $297M
Check the midpoint of Q2 guide. Above $320M signals acceleration. Below $310M signals deceleration.
Operating Cash Flow
$95.3M (Q4 2025)
Check OCF for any step-down that could indicate inventory build or customer payment timing shifts.
On the call · where thesis moves
How to read the outcomeQualitative (no specific %)
Revenue beat + Scorpio shipping to new hyperscalers + Q2 guide above $320M
Sharp rally. Market reprices ALAB from a retimer story to a multi-product platform with durable 80%+ YoY growth. Scorpio proof is the catalyst the stock needs.
Revenue beat + Scorpio timing unchanged + Q2 guide in line
Flat to modest fade. The beat is expected. Without Scorpio proof, the concentration discount persists. Momentum holders may trim on no new catalyst.
Revenue in line + Scorpio delayed + GM compression below 75%
Sharp selloff. Delays to the product diversification thesis combined with margin pressure would raise questions about whether ALAB can sustain premium multiples.
Revenue miss + Q2 guide below $310M + softer full-year tone
Severe selloff. A miss inside the guided range paired with decelerating forward guidance would break the growth narrative. Read-through weakens CRDO and broader AI connectivity names.
2213 signals · 103 high-quality · Alphabet, Meta Platforms confirmedResearch read-through · not a trade recommendation
✗Q2 guide midpoint below $310M paired with softer full-year commentary or language suggesting hyperscaler order timing is shifting out.
Taurus 800G AEC revenue timing
ALAB said Taurus AEC revenue would begin in early 2026. Confirmation of initial revenue would validate a third product vector. Silence or delays would narrow the near-term growth story to Aries plus Scorpio.
UALink standard adoption and design win pipeline
ALAB has framed UALink as a multibillion-dollar TAM by 2029. Any update on customer sampling or specification finalization would sharpen the long-duration thesis.
Hyperscaler capex commentary and order visibility
Amazon's recent guidance flagged memory supply and resource constraints as risks. Any ALAB commentary on order push-outs or extended lead times would signal whether connectivity demand is tracking capex plans.
PCIe 6 sole-source status and competitive dynamics
ALAB claimed sole-source for PCIe 6 retimers last quarter. Any mention of second-source qualification at a hyperscaler would weaken the pricing power thesis.
Scorpio content per XPU and rack-level attach rates
Management previously cited several hundred dollars of content per XPU in PCIe scale-up. Updated figures tied to Blackwell NVL72 or NVL144 racks would quantify the Scorpio TAM more precisely.